BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27573774)

  • 1. Studying Cancer Evolution in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Paulson TG
    Adv Exp Med Biol; 2016; 908():213-36. PubMed ID: 27573774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic alterations in malignant transformation of Barrett's esophagus.
    Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H
    Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.
    Beilstein M; Silberg D
    Gastroenterol Clin North Am; 2002 Jun; 31(2):461-79, ix. PubMed ID: 12134613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diversity during the development of Barrett's oesophagus-associated adenocarcinoma: how, when and why?
    Graham TA; McDonald SA
    Biochem Soc Trans; 2010 Apr; 38(2):374-9. PubMed ID: 20298186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
    Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
    Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus.
    Li X; Paulson TG; Galipeau PC; Sanchez CA; Liu K; Kuhner MK; Maley CC; Self SG; Vaughan TL; Reid BJ; Blount PL
    Cancer Prev Res (Phila); 2015 Sep; 8(9):845-56. PubMed ID: 26130253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: model of neoplastic progression.
    Ramel S
    World J Surg; 2003 Sep; 27(9):1009-13. PubMed ID: 12917763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.
    Maslyonkina KS; Konyukova AK; Alexeeva DY; Sinelnikov MY; Mikhaleva LM
    Cancer Med; 2022 Jan; 11(2):447-478. PubMed ID: 34870375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early events during neoplastic progression in Barrett's esophagus.
    Reid BJ
    Cancer Biomark; 2010; 9(1-6):307-24. PubMed ID: 22112482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Walch A; Mueller J; Höfler H; Werner M
    J Natl Cancer Inst; 2000 Jul; 92(14):1182-3. PubMed ID: 10904093
    [No Abstract]   [Full Text] [Related]  

  • 16. Early Barrett's carcinoma of the esophagus.
    Hölscher AH; Vallböhmer D; Bollschweiler E
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoplastic risk assessment in Barrett's esophagus: How far have we come?
    Noffsinger A
    Hum Pathol; 2003 Oct; 34(10):965-7. PubMed ID: 14608528
    [No Abstract]   [Full Text] [Related]  

  • 18. Barrett's: do we still need goblet cells for diagnosis?
    Lenglinger J; Riegler M
    Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
    [No Abstract]   [Full Text] [Related]  

  • 19. Short-segment Barrett's esophagus associated with high-grade dysplasia.
    Morita K; Fujimori T; Ono Y; Masuyama H; Nakamura T; Terano A
    J Gastroenterol; 2002; 37(12):1083-5. PubMed ID: 12522544
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.
    Chao DL; Maley CC; Wu X; Farrow DC; Galipeau PC; Sanchez CA; Paulson TG; Rabinovitch PS; Reid BJ; Spitz MR; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1935-40. PubMed ID: 17035402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.